Jonathan Avery

Jonathan Avery
OccupationsPsychiatrist, academic
Academic background
Alma materNew York University School of Medicine
Academic work
DisciplineAddiction medicine
Addiction psychiatry
InstitutionsWeill Cornell Medical College
NewYork-Presbyterian Hospital

Jonathan Avery is an American addiction psychiatrist and academic based at Weill Cornell Medical College.[1] At Weill Cornell, he serves as Vice Chair for Addiction Psychiatry and holds the endowed Stephen P. Tobin and Dr. Arnold M. Cooper Professorship in Consultation Liaison Psychiatry.[2] Avery hosts the podcast Thriving with Addiction and is the author of Thriving with Addiction: A New Model for Lasting Recovery and Health.[3][4][5] He is also the medical director of the NBA/NBPA Anti-Drug Program.[2][6]

Early life and education

Avery was born in the United States. His father was a hospice physician.[7]

Jonathan Avery earned his M.D. from New York University School of Medicine in 2009, followed by a psychiatry residency at NewYork-Presbyterian Hospital / Payne Whitney Clinic, where he was co-chief resident.[2] He later completed a specialization in addiction psychiatry at NYU School of Medicine.

Medical career

After fellowship, Avery joined the faculty at Weill Cornell Medical College and NewYork-Presbyterian Hospital.[1] He is now Program Director for the Addiction Psychiatry Fellowship and Vice Chair for Addiction Psychiatry in the Department of Psychiatry.[7]

He founded the Weill Cornell / New York-Presbyterian Program for Substance Use and Stigma of Addiction. The program was launched in 2019 and focuses on reducing stigma in medical settings, as well as improving intervention strategies.[7] Since 2023, he has been the medical director of the NBA/NBPA Anti-Drug Program. In 2026, Avery launched Thriving with Addiction, a podcast featuring conversations about addiction, recovery, and mental health. He is also the author of Thriving with Addiction: A New Model for Lasting Recovery and Health (2026), a book for a general audience about addiction treatment and long-term recovery.[3][4][5]

Research and advocacy

Avery's research topics include clinician attitudes toward patients with substance use disorders, adoption of buprenorphine, and stigma-reduction interventions for health care professionals and trainees.[2] He has authored or edited texts such as Co-occurring Mental Illness and Substance Use Disorders: A Guide to Diagnosis and Treatment[8] and The Stigma of Addiction: An Essential Guide.[9]

Selected publications

Selected publications by Avery include the following.[10]

References

  1. 1 2 "Jonathan Avery, MD, and Joseph Avery, JD, MA". Psychology Today. Retrieved August 5, 2025.
  2. 1 2 3 4 "Jonathan Avery, M.D." Patient Care. September 6, 2024. Retrieved August 5, 2025.
  3. 1 2 Avery, Jonathan (May 11, 2026). "What addiction medicine can teach us about depending on AI". STAT. Retrieved July 28, 2026.
  4. 1 2 "Thriving with Addiction". Simon & Schuster. Retrieved July 28, 2026.
  5. 1 2 "Thriving With Addiction Podcast". YouTube. March 6, 2024. Retrieved July 28, 2026.
  6. ↑ Spiers, Elizabeth (May 7, 2023). "The Drug That Saves Lives Even if It's Never Used". The New York Times. Retrieved August 5, 2025.
  7. 1 2 3 "Advances for Medical Professionals". NewYork-Presbyterian. Retrieved August 5, 2025.
  8. ↑ Avery, Jonathan D.; Barnhill, John W. (September 21, 2017). Co-occurring Mental Illness and Substance Use Disorders. Arlington, Virginia: American Psychiatric Pub. ISBN 978-1-61537-055-9.
  9. ↑ Avery, Jonathan D.; Avery, Joseph J., eds. (2019). The Stigma of Addiction: An Essential Guide. Cham: Springer International Publishing. doi:10.1007/978-3-030-02580-9. ISBN 978-3-030-02579-3.
  10. ↑ "Avery, Jonathan". VIVO. May 27, 2025. Retrieved August 5, 2025.
This page is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.